Former PalmSource CEO David Nagel Joins Epocrates Board
Epocrates Inc., provider of mobile and online clinical applications for healthcare professionals, today announced the appointment of David Nagel to its board of directors. Nagel will serve as Epocrates’ independent lead director and chair the board’s compensation committee.
Nagel is well recognized for his most recent role as president and chief executive officer of PalmSource, Inc., developer of operating system software platforms for handheld devices and smartphones. Nagel is currently president of Ascona Group.
"David Nagel is an exceptional addition to our board of directors. His leadership and experience in mobile and wireless technology will be valuable in guiding our management team,” said Kirk Loevner, chairman and chief executive officer of Epocrates.
Nagel’s extensive technology experience also includes senior management roles at several leading companies, including chief technology officer at AT&T and president of AT&T Labs. Nagel served as senior vice president at Apple Computer where he managed the advanced technology group and led the worldwide research and development group. Nagel also worked at NASA’s Ames Research Center as head of human factors research.
“The enthusiasm of Epocrates’ customer base is contagious. At PalmSource, I saw the ‘Epocrates phenomenon’ firsthand – clinicians purchasing mobile devices primarily to use Epocrates’ products. I am honored to be affiliated with a company that develops such valuable and reliable clinical solutions for healthcare professionals,” said Nagel.
Nagel currently serves on the board of directors of Leapfrog, Inc. (LFS), Tessera, Inc. (TSRA), ArcSoft and IDT Spectrum. Nagel is also a member of the Sciences Board of Visitors at UCLA where he earned a BS and MS in engineering and a PhD in perception and mathematical psychology.
In addition to Nagel, Epocrates recently welcomed Patrick Jones, former Intel controller and Dr. John Halamka, CIO of Harvard Medical School and Care Group Health Systems, to its board of directors.
About Epocrates
San Mateo, Calif.-based Epocrates is transforming the practice of medicine by providing innovative clinical solutions at the point of care and deploying leading-edge technologies that enable communication. The company has built a clinical network connecting more than 500,000 healthcare professionals, including one in four U.S. physicians and nearly one in two U.S. medical students, with the healthcare industry. Epocrates' products have shown a positive impact on patient safety, healthcare efficiency and patient satisfaction. Epocrates was recently ranked 257 in the 24th annual Inc.500 ranking of the fastest-growing private companies in the country. For more information about Epocrates, please visit
www.epocrates.com.
Linear Mode
